Clinical Trials Logo

Choroid Disease clinical trials

View clinical trials related to Choroid Disease.

Filter by:
  • None
  • Page 1

NCT ID: NCT06272851 Not yet recruiting - Diabetes Mellitus Clinical Trials

Measuring Choroidal Thickness Using Optical Coherence Tomography

Start date: March 15, 2024
Phase:
Study type: Observational

To compare the choroidal thickness in eyes of diabetic patients with eyes of age matched controls using optical coherence tomography.

NCT ID: NCT05623293 Recruiting - Carotid Stenosis Clinical Trials

Ophthalmologic Outcomes in Patients With Carotid Artery Stenosis

Start date: January 1, 2022
Phase:
Study type: Observational

The retinal vessels have been shown to reflect vascular changes inherent to systemic pathologies, even when no ocular disease is identified. As such, the eye's vasculature is ableto serve as a window to the vascular health of the human body and a means of assessing systemic endothelial function. Optical coherence tomography angiography (OCTA) employs optical means to image all the retinal vascular layers and the choroid, providing an extremely detailed image of the microvascular network in a fast, reproducible and totally non-invasive way. As such, it is currently the best non-invasive way of having an image of human capillaries. Recently, OCTA has been used to study the retinal vessels' structure and function in several cardiovascular diseases. As an example of its predictive potential, reduced retinal microvascular density has been associated with the cardiovascular risk profile in patients admitted to the hospital for an acute coronary syndrome. Recent studies have also shown the retinal microvasculature density to be reduced in patients with carotid artery disease (CAD), namely carotid stenosis, and that endarterectomy increases retinal flow and vessel density.

NCT ID: NCT05225597 Completed - Cataract Clinical Trials

The Effect of Intracameral Carbachol and Epinephrine on Choroidal Thickness

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

81 eyes of 81 patients undergoing cataract surgery were included in this prospective interventional study. During cataract surgery, intracameral carbachol was applied to 27 eyes, intracameral epinephrine was administered to 20 eyes and 34 eyes were the control group. Macular choroidal thickness measurement was performed before, 1 day, and 1 week after phacoemulsification surgery in all patients using optical coherence tomography.

NCT ID: NCT04255524 Not yet recruiting - Myopia, Progressive Clinical Trials

Choroidal Change on OCTA in Eyes With High Myopia

Start date: February 1, 2020
Phase: N/A
Study type: Interventional

Myopia is a global healthy concern, especially the high myopia and pathological myopia among Asian populations. However, its mechanism still remains largely unclear. Recent findings suggested choroidal changes might be related to the development of myopia. This study is to useOCT angiography (OCT-A) to investigate parapapillary choroidal microvasculature change in myopic eyes, and try to find the cause-and-effect relationship between choroidal change and the development of myopia.

NCT ID: NCT04075188 Completed - Clinical trials for Choroidal Neovascularization

Treatment of Polypoidal Choroidal Vasculopathy in Pachychoroid

Start date: September 18, 2017
Phase: N/A
Study type: Interventional

This study will evaluate patients with diagnosis of polypoidal choroidal vasculopathy (PCV) in pachychoroid treated with combined therapy, consisting in photodynamic therapy (PDT) and 3 intravitreal therapy (IVT) of Aflibercept monthly. This is a single center, prospective case-series study. The investigators are going to evaluate Corrected Distance Visual Acuity (CDVA), disease activity, retinal and choroidal thicknesses and number of injection per year, during a twelve month follow up. The aim of this study is to verify if the combined therapy can act on the insult induced by the pachychoroid and on the neovascular lesion itself in this sub-population of patients with PCV in pachychoroid,

NCT ID: NCT03811366 Completed - Inflammation Clinical Trials

Multimodal Analysis and Electroretinogram in VKH From Acute Onset - Part I

Start date: June 1, 2011
Phase: N/A
Study type: Interventional

Patients with acute onset Vogt-Koyanagi-Harada disease (VKHD) was prospectively included in this study. They were systematically followed with clinical, posterior segment imaging exams and full-field electroretinogram during a minimum 24-month of follow-up. All patients were treated with 3-day methylprednisolone pulse therapy followed by 1mg/day oral prednisone with a slow tapper during a median of 13 months. Non-steroidal immunosuppressive therapy (IMT) was introduced in cases of refractory disease or in cases of prednisone intolerance. Outcome measured by full-field electroretinogram was analyzed and patient was grouped as electroretinogram stable or electroretinogram worsening. Clinical data was analyzed in these two electroretinogram-based groups.

NCT ID: NCT03532867 Not yet recruiting - Choroid Disease Clinical Trials

Study of Changes in Retrofoveolar Choroidal Thickness During Aerobic Exercise

MOPAS
Start date: July 2019
Phase: N/A
Study type: Interventional

Study the change of retrofoveolar choroidal thickness measured by optical coherence tomography during aerobic exercise inducing an increase in systolic blood pressure in healthy subjects.Ten healthy participants will perform an exercise (riding a bicycle ergometer) and will be examined with EDI-OCT. Each participant will be scanned before exercise, during the exercise and afterwards at 0 and 5 min. Each OCT measurement will be coupled to the arterial blood pressure evaluation.

NCT ID: NCT03321253 Completed - Retinal Detachment Clinical Trials

Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification

Start date: October 23, 2015
Phase: N/A
Study type: Interventional

It has been hypothesized that potential effects of laser Nd: YAG laser posterior capsulotomy may affect macular pigment as well as choroidal thickness, macular thickness and anterior chamber parameters, so it was aimed to investigate possible effects of Nd: YAG laser posterior capsulotomy on macular pigment optical density, choroidal thickness, macular thickness and anterior chamber parameters in cases with posterior capsule opacification in this study.

NCT ID: NCT03144596 Completed - Clinical trials for Benign Prostatic Hyperplasia

The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil

Start date: October 29, 2015
Phase: Phase 4
Study type: Interventional

It was aimed to evaluate and investigate the effects of tamsulosin hydrochloride, has preferential selectivity for the α1A receptor in the prostat versus the α1B receptor in the blood vessels, and alfuzosin hydrochloride on choroidal thickness (CT), pupil diameter sizes evaluated by using enhanced depth imaging spectral-domain optical coherence tomography (EDI-OCT) and scheimpflug/placido photography-based topoghraphy system in this study. 63 men patients with newly diagnosis of benign prostatic hyperplasia were randomly assigned to either alfuzosin hydrochloride or to tamsulosin hydrochloride groups in this prospective, randomized, parallel-group clinical trial. Enhanced depth imaging spectral-domain optical coherence tomography, pupillography were obtained at baseline, 1st and 3rd month, and choroidal thicknesses and pupil diameter sizes were compared between the 2 groups.